Skip to main content

Sign in Register

Market DashboardMarkets, breadth and flows IndicesNSE & BSE benchmarks SectorsToday's rotation HeatmapSize = cap, colour = move BreadthAdvancers vs decliners FII/DIIInstitutional flows ValuationIs the market expensive?

SCREENER STOCKS FILINGS

Intelligence

Situations Conviction Broker Reports Earnings Deliveries Deals Corp. Actions

Discovery

Themes IPO Funds Community

PORTFOLIO MY AI

after·markets

Track what you own. Screen what you don't. India's market intelligence: screening, conviction scoring, and filing analysis, alive in real time.

Data: NSE & BSE

contact@aftermarkets.in

Markets

Market Dashboard
Screener
All Stocks
Heatmap
FII / DII

Research

Research hub
Filings
Conviction
Earnings
Broker Reports
Deliveries
Valuation
Deals
Themes
IPO Tracker
Funds & PMS

You

Portfolio
Trade Journal
Alerts
Watchlist
Get started

Company

About
Pricing
Learn
Developer / MCP
Terms
Privacy
Disclaimer

Operated by Chainlytics Advisory Services LLP.

© 2026 aftermarkets.in · Mumbai, IndiaInvestment in securities market are subject to market risks. Read all related documents carefully before investing.

GE

GENESIS IBRC INDIA LIMITED

BSE: GENESIS · Healthcare · Biotechnology · Market cap ₹406 Cr

₹89.62▴+4.26 (+4.99%)

· Prev close ₹85.36 · Volume 2

GENESIS IBRC INDIA ₹89.62 ▴+4.99%

⇧⌘K

Company research

Overview
Profitability2
Growth5
Valuation5
Financial health5
Ownership5
Price momentum6
Filings & calls9
Company8

Every dataset is a tab inside its group. Search finds any of them, including old names such as “concall”.
Find a dataset: Ctrl/⌘ Shift K
Find another stock: Ctrl/⌘ K

GENESIS IBRC INDIA › Filings & calls › Upcoming

Filings & calls

All activity Filings Earnings calls Walk the talk Broker reports Upcoming Dividends Corporate actions Situations

Upcoming events

Confirmed board meetings and corporate-action ex-dates, today through the next 90 days. These are announced dates, not estimated earnings dates.

Loading scheduled events…

← PreviousFilings & calls · Broker reports Next →Filings & calls · Dividends